Ich habe mir die Infos zu dem Deal nochmal angesehen. Schaut Euch mal den markierten Teil an. Da steht, dass MARAPHARM die Lizenz für 35 Mio Aktien von Standard Graphite verkauft. Standard Graphite hat aktuell unter 70 Mio Aktien ausgegeben. Das würde bedeuten, dass die Lizenz dennoch in Händen von Marapharm bleibt, da Standard Graphite am Ende Teil des Marapharm Besitzes wird. Wie seht Ihr das?
"Marapharm Ventures Inc. Marapharm Announces Letter of Intent to sell its ACMPR Application for $8.5 million
Marapharm Ventures Inc. (the Company) is pleased to announce that its wholly-owned subsidiary, Marapharm Inc. (Marapharm), has entered into a letter of intent (LOI) with Standard Graphite Corporation (SGH), a public company on the TSX Venture Exchange (TSXV) sell Marapharms Health Canada ACMPR (Access to Cannabis for Medical Purposes Regulations) license application, and all associated property, plans, and intellectual property to SGH, in consideration for $5.265 million CDN payable by 35,000,000 common shares more or less, dependent on price of SGH (the SGH Shares), plus $2.5 million, payable in shares based on receipt by Health Canada.